0000899243-22-025708.txt : 20220707 0000899243-22-025708.hdr.sgml : 20220707 20220707162540 ACCESSION NUMBER: 0000899243-22-025708 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220705 FILED AS OF DATE: 20220707 DATE AS OF CHANGE: 20220707 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOLD DANIEL P PHD CENTRAL INDEX KEY: 0001288233 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50484 FILM NUMBER: 221071910 MAIL ADDRESS: STREET 1: 10445 PACIFIC CENTER CT CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEI Pharma, Inc. CENTRAL INDEX KEY: 0001262104 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 510407811 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 11455 EL CAMINO REAL STREET 2: SUITE 250 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-369-7100 MAIL ADDRESS: STREET 1: 11455 EL CAMINO REAL STREET 2: SUITE 250 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: MARSHALL EDWARDS INC DATE OF NAME CHANGE: 20030902 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-07-05 0 0001262104 MEI Pharma, Inc. MEIP 0001288233 GOLD DANIEL P PHD C/O MEI PHARMA, INC. 11455 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130 1 1 0 0 Chief Executive Officer Stock Option (Right to Buy) 0.54 2022-07-05 4 A 0 1496000 0.00 A 2032-07-05 Common Stock 1496000 1496000 D Stock Option (Right to Buy) 2.95 2031-07-01 Common Stock 855000 855000 D Stock Option (Right to Buy) 1.57 2025-07-28 Common Stock 275500 275500 D Stock Option (Right to Buy) 1.36 2026-07-29 Common Stock 380000 380000 D Stock Option (Right to Buy) 2.83 2027-07-06 Common Stock 380000 380000 D Stock Option (Right to Buy) 4.33 2028-06-22 Common Stock 380000 380000 D Stock Option (Right to Buy) 4.28 2028-07-12 Common Stock 300000 300000 D Stock Option (Right to Buy) 2.52 2029-07-01 Common Stock 675000 675000 D Stock Option (Right to Buy) 3.49 2030-07-02 Common Stock 680000 680000 D One-quarter of such options shall vest on July 5, 2023 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 5, 2023. One-quarter of such options vested on July 1, 2022 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2022. All of such options are presently exercisable. One-quarter of such options vested on July 12, 2019 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 12, 2019. One-quarter of such options vested on July 1, 2020 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2020. One-quarter of such options vested on July 2, 2021 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 2, 2021. /s/ Brian G. Drazba, as attorney in fact 2022-07-07